Amphastar Pharmaceuticals, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2013 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Amphastar Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2013 to Q3 2024.
  • Amphastar Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $7.25M, a 48.3% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $28.3M, a 17.7% decline year-over-year.
  • Amphastar Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $31.8M, a 35.6% increase from 2022.
  • Amphastar Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $23.5M, a 13.8% increase from 2021.
  • Amphastar Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $20.6M, a 483% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $28.3M $7.25M -$6.77M -48.3% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $35.1M $12.3M +$5.91M +92.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $29.2M $4.13M -$2.63M -38.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $31.8M $4.67M -$2.62M -35.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $34.5M $14M +$7.47M +114% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $27M $6.38M +$832K +15% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $26.2M $6.75M +$2.68M +65.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $23.5M $7.29M +$96K +1.33% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $23.4M $6.56M -$127K -1.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $23.5M $5.55M -$44K -0.79% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $23.6M $4.08M +$2.92M +253% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $20.6M $7.19M +$8.14M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $12.5M $6.69M +$4.4M +193% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $8.09M $5.6M +$5.67M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $2.42M $1.16M -$1.13M -49.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $3.54M -$950K -$1.38M -320% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-01
Q3 2020 $4.92M $2.29M +$1.69M +282% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $3.23M -$75K -$14.2M -101% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $17.5M $2.28M +$3.76M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $13.7M $431K +$1.56M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-11
Q3 2019 $12.2M $598K -$360K -37.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $12.5M $14.2M +$15.5M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$3M -$1.48M +$269K +15.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 -$3.27M -$1.13M +$868K +43.5% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-15
Q3 2018 -$4.13M $958K +$3.17M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$7.31M -$1.35M -$2.55M -212% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$4.76M -$1.75M -$2.36M -386% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$2.4M -$2M -$512K -34.5% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-16
Q3 2017 -$1.89M -$2.21M -$4.32M -205% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $2.44M $1.2M -$1.66M -58% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $4.09M $611K -$716K -54% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 $4.81M -$1.49M -$4.29M -153% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-15
Q3 2016 $9.1M $2.11M +$3.38M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $5.72M $2.86M +$6.44M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$718K $1.33M +$6.86M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$7.58M $2.81M +$6.1M Oct 1, 2015 Dec 31, 2015 10-K 2018-03-14
Q3 2015 -$13.7M -$1.27M +$1.34M +51.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$15M -$3.58M -$2.89M -415% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$12.1M -$5.53M -$4.68M -549% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$7.45M -$3.3M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$2.61M -$3.1M -627% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-13
Q2 2014 -$696K -$4.81M -117% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$852K Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-14
Q3 2013 $494K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 $4.11M Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.